Elisa Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elisa Lin has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Franklin Fuda
Department of Pathology University of Texas Southwestern Medical Center Dallas Texas USA
2 shared publications- Mingyi Chen
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, USA
2 shared publications - Adelaide J. Kwon
Department of Pathology University of Texas Southwestern Medical Center Dallas Texas USA
1 shared publication Andrew M. Cox
Cell & Molecular Biology | Luda Hill Department of Bioinformatics, University of Texas, Southwestern Medical Center, Dallas, Texas, United States of America
1 shared publication- Ellen Araj
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75019, USA
1 shared publication Estelle E. Oertling
Department of Pathology University of Texas Southwestern Medical Center Dallas Texas USA
1 shared publication
Latest Publications
- 21 January 2025
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 47 (3) , 445-453
Clinicopathologic and Molecular Characterization of NUP98‐Rearranged Acute Leukemias
Introduction: NUP98 rearrangements are rare in acute leukemias and portend a poor prognosis.Methods: This study explored clinicopathologic and molecular features of five patients with NUP98 rearranged (NUP98‐r) acute leukemias, including three females and two males with a median age of 34 years.Results: NUP98 fusion partners were associated with distinctive leukemia characteristics and biology. Three patients had NUP98::NSD1‐r acute myeloid leukemia (AML, all cytogenetically cryptic and with concomitant FLT3‐ITD) and unfavorable prognoses (in two patients), one patient had NUP98::HOXA9‐r AML with morphologic and immunophenotypic features resembling acute promyelocytic leukemia, and lastly, one patient had previously underreported NUP98::MLLT1‐r B/T mixed phenotype acute leukemia. After a median follow‐up of 24.7 months, median overall survival was 30 months and three of five patients (60%) remained in complete remission at the last follow‐up.Conclusion: Our study expands the clinical and molecular spectrum of NUP98‐r acute leukemias and recommends FISH testing for NUP98 rearrangement on those leukemia cases without recurrent gene rearrangements and/or normal karyotype followed by molecular confirmation to improve timely diagnosis and clinical management.
- 21 January 2025
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 47 (3) , 445-453
Clinicopathologic and Molecular Characterization of NUP98‐Rearranged Acute Leukemias
Introduction: NUP98 rearrangements are rare in acute leukemias and portend a poor prognosis.Methods: This study explored clinicopathologic and molecular features of five patients with NUP98 rearranged (NUP98‐r) acute leukemias, including three females and two males with a median age of 34 years.Results: NUP98 fusion partners were associated with distinctive leukemia characteristics and biology. Three patients had NUP98::NSD1‐r acute myeloid leukemia (AML, all cytogenetically cryptic and with concomitant FLT3‐ITD) and unfavorable prognoses (in two patients), one patient had NUP98::HOXA9‐r AML with morphologic and immunophenotypic features resembling acute promyelocytic leukemia, and lastly, one patient had previously underreported NUP98::MLLT1‐r B/T mixed phenotype acute leukemia. After a median follow‐up of 24.7 months, median overall survival was 30 months and three of five patients (60%) remained in complete remission at the last follow‐up.Conclusion: Our study expands the clinical and molecular spectrum of NUP98‐r acute leukemias and recommends FISH testing for NUP98 rearrangement on those leukemia cases without recurrent gene rearrangements and/or normal karyotype followed by molecular confirmation to improve timely diagnosis and clinical management.
- 15 February 2023
- Published by Elsevier in Seminars in Diagnostic Pathology
- Vol. 40 (2) , 88-94
Digital pathology and artificial intelligence as the next chapter in diagnostic hematopathology
- 15 February 2023
- Published by Elsevier in Seminars in Diagnostic Pathology
- Vol. 40 (2) , 88-94
Digital pathology and artificial intelligence as the next chapter in diagnostic hematopathology
- Open Access
- 11 July 2022
- Published by MDPI AG in Hematology Reports
- Vol. 14 (3) , 228-234
Hematologic Complications in Patients Hospitalized with COVID-19 Infection
Introduction: This review summarizes data from patients with COVID-19 requiring intensive care unit (ICU) admission. The goals of this study are to showcase some morphological anomalies found in peripheral blood smears from COVID-19 patients and to bring attention to how some hematologic abnormalities in COVID-19 that correspond to disease severity and mortality. Methods: We performed a retrospective analysis of hematologic parameters using peripheral blood smear analysis from 31 COVID-19 patients hospitalized between April 2021 and January 2022. Results: We found abnormal morphology that has not been previously reported. We also report that severe lymphopenia, neutrophilia, acute hemolysis, hematologic malignancies, and increased LDH are associated with ICU admissions, respiratory failure requiring intubation, and poor clinical outcome. Conclusion: We propose these recommendations in the management of COVID-19 patients: 1. Early diagnosis and follow-up of DIC; 2. Optimization of thromboprophylaxis regimen.
- 11 July 2022
- Published by MDPI AG in Hematology Reports
- Vol. 14 (3) , 228-234
Open AccessHematologic Complications in Patients Hospitalized with COVID-19 Infection
Introduction: This review summarizes data from patients with COVID-19 requiring intensive care unit (ICU) admission. The goals of this study are to showcase some morphological anomalies found in peripheral blood smears from COVID-19 patients and to bring attention to how some hematologic abnormalities in COVID-19 that correspond to disease severity and mortality. Methods: We performed a retrospective analysis of hematologic parameters using peripheral blood smear analysis from 31 COVID-19 patients hospitalized between April 2021 and January 2022. Results: We found abnormal morphology that has not been previously reported. We also report that severe lymphopenia, neutrophilia, acute hemolysis, hematologic malignancies, and increased LDH are associated with ICU admissions, respiratory failure requiring intubation, and poor clinical outcome. Conclusion: We propose these recommendations in the management of COVID-19 patients: 1. Early diagnosis and follow-up of DIC; 2. Optimization of thromboprophylaxis regimen.
- 1 September 2015
- Published by Elsevier in Journal of Organometallic Chemistry
- Vol. 792, 184-189
Iridium catalyzed reversible dehydrogenation – Hydrogenation of quinoline derivatives under mild conditions
- 1 September 2015
- Published by Elsevier in Journal of Organometallic Chemistry
- Vol. 792, 184-189
Iridium catalyzed reversible dehydrogenation – Hydrogenation of quinoline derivatives under mild conditions